The large block sale by BVF Partners and concurrent heavy selling by the CEO and CFO suggest a lack of confidence in near-term catalysts. Traders should watch for upcoming clinical data or earnings announcements that could explain the insider selling. The stock may face near-term pressure, but the strong analyst consensus (93% bullish) provides a counterbalance.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 6 $113.51entry
- T+1 · 4mo ago +1.10%α +0.23% · $114.76
- T+5 · 4mo ago +4.84%α +3.91% · $119.00
- T+20 · 4mo ago −5.73%α −5.31% · $107.01
- T+60 · 7w ago −1.33%α −4.90% · $112.00
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kymera Therapeutics (KYMR) saw a massive insider selling cluster over the past week, with total open-market sales exceeding $109 million, including a $89.2 million block sale by director BVF Partners. The CEO and CFO sold approximately $9.2M and $8.9M, respectively, after exercising options. This represents about 1.2% of the company's $9.4B market cap, a significant insider outflow that warrants caution given the lack of disclosed positive catalysts.
Key Financial Metrics
Key Facts
- CEO Nello Mainolfi sold ~$9.2M in open-market shares (80,000 shares) on July 1, 2026, after exercising options.
- CFO Bruce Jacobs sold ~$8.9M in open-market shares (77,109 shares) on June 30, 2026, after exercising options.
- Director BVF Partners (Booth Bruce) sold $89.2M in a single block trade on June 26, 2026.
- Total insider selling exceeds $109M, or ~1.2% of the $9.4B market cap.
- Net direction is overwhelmingly selling, with no insider purchases in the cluster.
Financial Impact
Total insider selling of ~$109M, about 1.2% of market cap, concentrated among top executives and a major director.
Risk Factors
- Insider selling could signal undisclosed negative news or a peak in the stock price.
- The BVF sale may represent a strategic exit, reducing a major insider's stake.
- Option exercises followed by sales are often routine, but the magnitude here is outsized.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KYMR-1783033308016 |
Track record
37 reports on KYMR
6 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 8 of 13 went positive at some point.
Filters
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
- Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
- Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers